JPS61129120A - アニリン誘導体よりなる抗腫瘍剤 - Google Patents
アニリン誘導体よりなる抗腫瘍剤Info
- Publication number
- JPS61129120A JPS61129120A JP25128784A JP25128784A JPS61129120A JP S61129120 A JPS61129120 A JP S61129120A JP 25128784 A JP25128784 A JP 25128784A JP 25128784 A JP25128784 A JP 25128784A JP S61129120 A JPS61129120 A JP S61129120A
- Authority
- JP
- Japan
- Prior art keywords
- antitumor agent
- active ingredient
- aniline derivative
- substance
- antitumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002246 antineoplastic agent Substances 0.000 title claims abstract description 8
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 title abstract 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 18
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 241001465754 Metazoa Species 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 239000003085 diluting agent Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 239000002674 ointment Substances 0.000 abstract description 2
- 238000007911 parenteral administration Methods 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 239000000829 suppository Substances 0.000 abstract description 2
- 210000004881 tumor cell Anatomy 0.000 abstract description 2
- 239000003708 ampul Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000004503 fine granule Substances 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25128784A JPS61129120A (ja) | 1984-11-28 | 1984-11-28 | アニリン誘導体よりなる抗腫瘍剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25128784A JPS61129120A (ja) | 1984-11-28 | 1984-11-28 | アニリン誘導体よりなる抗腫瘍剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61129120A true JPS61129120A (ja) | 1986-06-17 |
| JPH0344049B2 JPH0344049B2 (enrdf_load_stackoverflow) | 1991-07-04 |
Family
ID=17220558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25128784A Granted JPS61129120A (ja) | 1984-11-28 | 1984-11-28 | アニリン誘導体よりなる抗腫瘍剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61129120A (enrdf_load_stackoverflow) |
-
1984
- 1984-11-28 JP JP25128784A patent/JPS61129120A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0344049B2 (enrdf_load_stackoverflow) | 1991-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3465824B2 (ja) | 腫瘍治療用医薬組成物 | |
| JPS61129129A (ja) | 抗腫瘍剤 | |
| GB2174391A (en) | 5-pyrimidinecarboxamides and treatment of leukemia and tumours therewith | |
| JPS61129120A (ja) | アニリン誘導体よりなる抗腫瘍剤 | |
| JPS5849315A (ja) | 抗腫瘍剤 | |
| JPS61129122A (ja) | アントラニル酸誘導体よりなる抗腫瘍剤 | |
| JPH07277964A (ja) | 抗腫瘍剤 | |
| JPS61129124A (ja) | 抗腫瘍剤 | |
| HUP0203790A2 (hu) | (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére | |
| JPS61129131A (ja) | サリチル酸誘導体よりなる抗腫瘍剤 | |
| JPH0548207B2 (enrdf_load_stackoverflow) | ||
| JPS61129125A (ja) | 抗腫瘍剤 | |
| JPS61130218A (ja) | 抗腫瘍剤 | |
| US3129137A (en) | Method of inhibiting gastro-intestinal irritation | |
| JPS61129128A (ja) | 抗腫瘍剤 | |
| JPS61129121A (ja) | 抗腫瘍剤 | |
| JPS61130221A (ja) | 抗腫瘍剤 | |
| JPS61130217A (ja) | 酢酸誘導体を含有する抗腫瘍剤 | |
| JPH03502802A (ja) | 抗嘔吐性エルゴリン誘導体 | |
| JPS63146813A (ja) | ジテルペン系化合物を含んで成る制癌剤 | |
| JPS61130224A (ja) | 抗腫瘍剤 | |
| JPS61130222A (ja) | 抗腫瘍剤 | |
| JPS63146839A (ja) | プテロシン系化合物を含んで成る制癌剤 | |
| JPS61130216A (ja) | 抗腫瘍剤 | |
| JPH0616546A (ja) | 酢酸誘導体を含有する抗腫瘍剤 |